Related Experiment Video
Updated: Apr 18, 2026

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Cardiovascular complications in inflammatory bowel disease
Rudolf Schicho, Gunther Marsche, Martin Storr1
1Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Austria. rudolf.schicho@medunigraz.at.
Inflammatory bowel disease (IBD) patients face higher cardiovascular disease risks due to shared inflammation and gut microbiota changes. These factors contribute to endothelial dysfunction and atherosclerosis, increasing cardiac event likelihood.
Area of Science:
- Gastroenterology and Cardiology
- Immunology and Microbiology
Background:
- Inflammatory bowel disease (IBD) and cardiovascular disease (CVD) are chronic inflammatory conditions.
- Shared pathophysiological mechanisms link IBD and increased CVD risk.
Purpose of the Study:
- To explore the intricate relationship between IBD and cardiovascular disease.
- To elucidate the underlying mechanisms connecting these two chronic inflammatory conditions.
Main Methods:
- Review of existing studies linking IBD and CVD.
- Analysis of shared inflammatory pathways, including cytokines and C-reactive protein (CRP).
- Investigation of lipid profiles, coagulation factors, and gut microbiota's role in IBD-associated CVD.
Main Results:
- IBD patients exhibit elevated cytokines, CRP, and homocysteine, promoting endothelial dysfunction and atherosclerosis.
- Altered lipid profiles and increased coagulation factors in IBD patients predispose to thromboembolic events.
- Gut microbiota dysbiosis and microbial translocation contribute to systemic inflammation and atherogenesis in IBD.
Conclusions:
- A significant link exists between IBD and cardiovascular disease, supported by retrospective studies.
- Inflammation, endothelial dysfunction, and gut microbiome alterations are key mechanisms.
- Further research is needed to fully determine the causal pathways.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

